Legal Opinion
Regeneron Pharmaceuticals, Inc. v. Amgen Inc.
District Court, D. Delaware
Decided February 10, 2023No. 1:22-cv-00697Unknown
1Opinion
IN THE UNITED STATES DISTRICT COURT FOR THE DISTRICT OF DELAWARE REGENERON PHARMACEUTICALS, INC., Plaintiff, v. C.A. No. 22-697-RGA-JLH AMGEN INC., Defendant. REPORT AND RECOMMENDATION AND ORDER Pending before the Court are two motions filed by Defendant Amgen Inc.: its Motion to Dismiss (D.I. 17) and its Motion to Stay (D.I. 27).1 The motions are fully briefed (D.I. 18, 19, 28, 34, 35, 36, 40, 41, 43, 47, 48), and I heard oral argument on January 6, 2023 (“Tr. __”). For the reasons below, I recommend that Amgen’s motion to dismiss be DENIED, and I order that Amgen’s motion to stay is DENIED.…
2Cases cited20 opinions
- Ashcroft v. IqbalSupreme Court of the United States · 2009
- Bell Atlantic Corp. v. TwomblySupreme Court of the United States · 2007
- Eastman Kodak Co. v. Image Technical Services, Inc.Supreme Court of the United States · 1992
- Karim Khoja v. Orexigen Therapeutics, Inc.Court of Appeals for the Ninth Circuit · 2018
- Alan Schmidt v. John SkolasCourt of Appeals for the Third Circuit · 2014
15 more not listed; retrieve them via the Exa API.